PT  - JOURNAL ARTICLE
AU  - Thindwa, Deus
AU  - Li, Ke
AU  - Cooper-Wootton, Dominic
AU  - Zheng, Zhe
AU  - Pitzer, Virginia E
AU  - Weinberger, Daniel M
TI  - Global patterns of rebound to normal RSV dynamics following COVID-19 suppression
AID  - 10.1101/2024.02.23.24303265
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.02.23.24303265
4099  - http://medrxiv.org/content/early/2024/02/24/2024.02.23.24303265.short
4100  - http://medrxiv.org/content/early/2024/02/24/2024.02.23.24303265.full
AB  - Introduction Annual epidemics of respiratory synctial virus (RSV) had consistent timing and intensity between seasons prior to the SARS-CoV-2 pandemic (COVID-19). However, starting in April 2020, RSV seasonal activity declined due to COVID-19 non-pharmaceutical interventions (NPIs) before re-emerging after relaxation of NPIs. We described the unusual patterns of RSV epidemics that occurred in multiple subsequent waves following COVID-19 in different countries and explored factors associated with these patterns.Methods Weekly cases of RSV from twenty-eight countries were obtained from the World Health Organisation and combined with data on country-level characteristics and the stringency of the COVID-19 response. Dynamic time warping and regression were used to describe epidemic characteristics, cluster time series patterns, and identify related factors.Results While the first wave of RSV epidemics following pandemic suppression exhibited unusual patterns, the second and third waves more closely resembled typical RSV patterns in many countries. Post-pandemic RSV patterns differed in their intensity and/or timing, with several broad patterns across the countries. The onset and peak timings of the first and second waves of RSV epidemics following COVID-19 suppression were earlier in the Southern Hemisphere. The second wave of RSV epidemics was also earlier with higher population density, and delayed if the intensity of the first wave was higher. More stringent NPIs were associated with lower RSV growth rate and intensity and a shorter gap between the first and second waves.Conclusion Patterns of RSV activity have largely returned to normal following successive waves in the post-pandemic era. Onset and peak timings of future epidemics following disruption of normal RSV dynamics need close monitoring to inform the delivery of preventive and control measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in manuscript was fully supported by the National Institutes of Health (NIH) under award number R01AI137093. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:These analyses used publicly available aggregate time series data at the country level and thus did not contain any data on individual human subjects. These analyses followed the guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment. Data are originally located at https://frontdoor-l4uikgap6gz3m.azurefd.net/FLUMART/VIW_FNT?$format=csvI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data used in this analysis are publicly available in the GitHub repository (https://github.com/deusthindwa/rsv.rebound.normal.seasonality.global)